EuroFlow is a renowned brand in the field of flow cytometry and molecular diagnostics. Comprised of over 20 diagnostic research groups and a specialized small and medium-sized enterprise (SME), EuroFlow is recognized for its expertise in highly sensitive flow cytometric tests for the diagnosis and follow-up of hematological malignancies. Since its establishment in 2006, EuroFlow has been dedicated to the development and standardization of fast, accurate, and highly sensitive flow cytometric tests for the precise (sub)classification and prognostic evaluation of these malignancies.

By introducing innovative flow cytometric methods, EuroFlow aims to replace time-consuming molecular techniques, including PCR-based detection. EuroFlow collaborates closely with ESLHO, the European Scientific foundation for Laboratory Hemato-Oncology, and is supported by other foundations such as EuroClonality and EuroMRD, with the common objective of advancing laboratory diagnostics in hematology. Through their cutting-edge technologies, EuroFlow strives to provide improved early diagnosis, precise disease monitoring, and individualized treatment, ultimately contributing to advancements in healthcare and strengthening European biotechnology enterprises